US BANCORP \DE\ - GENMAB A/S ownership

GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 209 filers reported holding GENMAB A/S in Q2 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of GENMAB A/S
ValueSharesWeighting
Q3 2023$6,409,617
+67.8%
181,730
+80.8%
0.01%
+66.7%
Q2 2023$3,820,651
+4.7%
100,517
+4.1%
0.01%0.0%
Q1 2023$3,647,730
-12.3%
96,603
-1.6%
0.01%
-14.3%
Q4 2022$4,158,538
+39.9%
98,125
+6.1%
0.01%
+16.7%
Q3 2022$2,972,000
+55.1%
92,511
+56.9%
0.01%
+50.0%
Q2 2022$1,916,000
-32.7%
58,980
-25.1%
0.00%
-20.0%
Q1 2022$2,849,000
-5.3%
78,711
+3.5%
0.01%0.0%
Q4 2021$3,007,000
-7.7%
76,024
+2.0%
0.01%
-16.7%
Q3 2021$3,259,000
+29.5%
74,530
+20.9%
0.01%
+20.0%
Q2 2021$2,516,000
+197.4%
61,621
+139.1%
0.01%
+150.0%
Q1 2021$846,000
-9.6%
25,775
+12.1%
0.00%0.0%
Q4 2020$936,000
-51.5%
22,990
-56.3%
0.00%
-60.0%
Q3 2020$1,929,000
+727.9%
52,651
+665.1%
0.01%
+400.0%
Q2 2020$233,000
+62.9%
6,882
+1.7%
0.00%
Q1 2020$143,000
-7.7%
6,767
-2.5%
0.00%
Q4 2019$155,000
+47.6%
6,939
+33.1%
0.00%
Q3 2019$105,0005,2120.00%
Other shareholders
GENMAB A/S shareholders Q2 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 242,848$9,169,9403.80%
Capricorn Fund Managers Ltd 110,643$4,177,8801.28%
Arlington Capital Management, Inc. 35,591$1,343,9161.26%
XY Capital Ltd 76,884$2,903,1401.13%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 88,000$3,322,8800.93%
TORRAY INVESTMENT PARTNERS LLC 110,807$4,184,0720.75%
Hardman Johnston Global Advisors LLC 585,139$22,094,8490.72%
Yorktown Management & Research Co Inc 16,600$626,8160.68%
First Light Asset Management, LLC 160,025$6,042,5440.54%
MIRABELLA FINANCIAL SERVICES LLP 28,260$2,505,8550.38%
View complete list of GENMAB A/S shareholders